Eagle Meds Services
TABRECTA (capmatinib)
Available to sourceHuman Prescription DrugOncology & Specialty

TABRECTA (capmatinib)

Active ingredients · Capmatinib Hydrochloride

200 mg/1 · Film-Coated Tablet
By Novartis Pharmaceuticals Corporation
NDC
0078-0716
Route
Oral
Therapeutic class
Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inhibitors [MoA], Kinase Inhibitor , Mesenchymal Epithelial Transition Inhibitors [MoA], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
Marketing category
NDA

Package sizes

  • 56 TABLET, FILM COATED in 1 BOTTLE (0078-0716-56)NDC 0078-0716-56Available to order
  • 56 TABLET, FILM COATED in 1 BOTTLE (0078-0716-94)NDC 0078-0716-94Available to order

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.

Request this medication

Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.

Requesting
TABRECTA (capmatinib)
NDC 0078-0716
(980) 480-3410 requests@eaglemedsservices.com

Related in Oncology & Specialty

See all →
Verzenio (abemaciclib)

Verzenio (abemaciclib)

50 mg/1 · Tablet
Eli Lilly and Company
Available to source
Verzenio (abemaciclib)

Verzenio (abemaciclib)

200 mg/1 · Tablet
Eli Lilly and Company
Available to source
Verzenio (abemaciclib)

Verzenio (abemaciclib)

100 mg/1 · Tablet
Eli Lilly and Company
Available to source
Verzenio (abemaciclib)

Verzenio (abemaciclib)

150 mg/1 · Tablet
Eli Lilly and Company
Available to source